{"hands_on_practices": [{"introduction": "A cornerstone of immunology is the ability to distinguish between different immune cell populations based on their molecular signatures. This practice places you in the role of a researcher analyzing single-cell data, a common task in modern immunology labs. By applying your knowledge of the canonical protein markers that define granulocyte lineages, you will learn to construct a logical decision rule to classify an unknown cell, a skill essential for interpreting complex experimental results [@problem_id:2862292].", "problem": "A single-cell cytometry dataset reports normalized abundances (unitless, centered to the granulocyte-wide median so that values around $1$ reflect median expression) of selected granule proteases and surface receptors in one unknown granulocyte. You are to classify this cell as a neutrophil, eosinophil, or basophil using first principles about lineage-restricted granule proteases and canonical receptor repertoires, and select the option whose decision rule is both immunologically sound and consistent with the data.\n\nFundamental facts to use:\n- Granulocytes are innate immune effector cells whose lineages are distinguished by dominant granule effectors: neutrophils store myeloperoxidase (MPO), neutrophil elastase (ELANE), and proteinase $3$ (PR3) in azurophilic granules; eosinophils store eosinophil peroxidase (EPX), major basic protein (PRG2, also known as MBP), and eosinophil cationic protein; basophils store histamine and proteoglycans and, unlike mast cells, have minimal chymase or tryptase and lack MPO and EPX.\n- Receptor patterns are also distinctive: neutrophils are characterized by C-X-C chemokine receptor type $2$ (CXCR$2$) and Fc gamma receptor IIIB (Fc$\\gamma$RIIIB, CD$16$b); eosinophils by C-C chemokine receptor type $3$ (CCR$3$), Interleukin-5 receptor alpha (IL-5R$\\alpha$), Sialic acid-binding immunoglobulin-type lectin $8$ (Siglec-$8$), and Prostaglandin D$2$ receptor $2$ (CRTH2, PTGDR$2$); basophils by high-affinity immunoglobulin E receptor (Fc$\\varepsilon$RI) and Cluster of Differentiation $123$ (CD123, Interleukin-3 receptor alpha), with variable CCR$3$ and CRTH2.\n\nThe unknown cell’s measurements:\n- Granule proteases:\n  - Myeloperoxidase (MPO): $0.05$\n  - Neutrophil elastase (ELANE): $0.08$\n  - Proteinase $3$ (PR3): $0.06$\n  - Eosinophil peroxidase (EPX): $1.80$\n  - Major basic protein (PRG2/MBP): $2.10$\n  - Carboxypeptidase A$3$ (CPA$3$): $0.02$\n  - Tryptase (TPSAB$1$): $0.01$\n- Receptors:\n  - High-affinity immunoglobulin E receptor (Fc$\\varepsilon$RI): $0.10$\n  - C-C chemokine receptor type $3$ (CCR$3$): $1.60$\n  - Interleukin-5 receptor alpha (IL-5R$\\alpha$): $1.70$\n  - C-X-C chemokine receptor type $2$ (CXCR$2$): $0.20$\n  - Fc gamma receptor IIIB (Fc$\\gamma$RIIIB, CD$16$b): $0.10$\n  - Cluster of Differentiation $123$ (CD123): $0.30$\n  - Prostaglandin D$2$ receptor $2$ (CRTH2): $0.90$\n  - Sialic acid-binding immunoglobulin-type lectin $8$ (Siglec-$8$): $1.50$\n\nWhich option gives a correct classification and an immunologically valid, minimally sufficient decision rule to discriminate among neutrophils, eosinophils, and basophils on the basis of these data?\n\nA. Classify as eosinophil if eosinophil-restricted granule proteins are dominant and neutrophil azurophilic proteases are suppressed: specifically, if EPX and PRG$2$ both exceed $1.5$, MPO/ELANE/PR$3$ are each less than $0.5$, and the receptor pattern shows high CCR$3$ and IL-$5$R$\\alpha$ with low Fc$\\varepsilon$RI and CXCR$2$.\n\nB. Classify as basophil if type $2$ chemotaxis markers are present even without IgE receptor dominance: specifically, if CCR$3$ and CRTH$2$ are each at least $0.8$ and CD$123$ exceeds $0.2$, regardless of EPX, PRG$2$, or Fc$\\varepsilon$RI levels.\n\nC. Classify as neutrophil whenever any chemokine receptor is detectable and MPO is not strongly elevated: specifically, if any of CCR$3$, CXCR$2$, or CRTH$2$ exceeds $0.5$ while MPO is below $1.0$.\n\nD. Classify as basophil if any mast cell–type protease is detectable: specifically, if either CPA$3$ or tryptase (TPSAB$1$) is nonzero, irrespective of Fc$\\varepsilon$RI or EPX status.", "solution": "The problem requires the classification of an unknown granulocyte based on a provided dataset of normalized protein abundances. The classification must be grounded in fundamental immunological principles that distinguish neutrophils, eosinophils, and basophils.\n\nFirst, the validity of the problem statement must be assessed.\n\n### Step 1: Extract Givens\n\n- **Cell Type to Classify**: One unknown granulocyte, to be identified as a neutrophil, eosinophil, or basophil.\n- **Dataset**: Single-cell cytometry data reporting normalized abundances (unitless, centered to the granulocyte-wide median, with values around $1$ reflecting median expression).\n- **Fundamental Facts (Lineage Markers)**:\n    - **Neutrophils**: Granule proteins: Myeloperoxidase (MPO), neutrophil elastase (ELANE), proteinase $3$ (PR3). Receptors: C-X-C chemokine receptor type $2$ (CXCR$2$), Fc gamma receptor IIIB (Fc$\\gamma$RIIIB/CD$16$b).\n    - **Eosinophils**: Granule proteins: Eosinophil peroxidase (EPX), major basic protein (PRG2/MBP). Receptors: C-C chemokine receptor type $3$ (CCR$3$), Interleukin-5 receptor alpha (IL-5R$\\alpha$), Sialic acid-binding immunoglobulin-type lectin $8$ (Siglec-$8$), Prostaglandin D$2$ receptor $2$ (CRTH2/PTGDR$2$).\n    - **Basophils**: Granule contents: Histamine, proteoglycans. Minimal chymase/tryptase. Lack MPO and EPX. Receptors: High-affinity immunoglobulin E receptor (Fc$\\varepsilon$RI), Cluster of Differentiation $123$ (CD123/IL-$3$R$\\alpha$). Variable CCR$3$ and CRTH2.\n- **Data for the Unknown Cell**:\n    - Granule Proteases:\n        - MPO: $0.05$\n        - ELANE: $0.08$\n        - PR3: $0.06$\n        - EPX: $1.80$\n        - PRG2/MBP: $2.10$\n        - Carboxypeptidase A$3$ (CPA$3$): $0.02$\n        - Tryptase (TPSAB$1$): $0.01$\n    - Receptors:\n        - Fc$\\varepsilon$RI: $0.10$\n        - CCR$3$: $1.60$\n        - IL-5R$\\alpha$: $1.70$\n        - CXCR$2$: $0.20$\n        - Fc$\\gamma$RIIIB: $0.10$\n        - CD123: $0.30$\n        - CRTH2: $0.90$\n        - Siglec-$8$: $1.50$\n- **Task**: Select the option whose decision rule is both immunologically sound and consistent with the data for discriminating among the three granulocyte lineages.\n\n### Step 2: Validate Using Extracted Givens\n\nThe problem is scientifically grounded, drawing upon established principles of immunology for cell identification. The markers listed (e.g., MPO, EPX, CCR$3$, CXCR$2$) are canonical for their respective lineages. The problem is well-posed, as the provided data and principles are sufficient to arrive at a unique classification. The language is objective and precise. The numerical data are plausible for normalized expression values. The problem does not violate any of the criteria for invalidity.\n\n### Step 3: Verdict and Action\n\nThe problem is valid. A solution will be derived.\n\n### Derivation of Cell Identity\n\nThe classification of the unknown cell proceeds by comparing its measured protein expression profile against the canonical profiles of neutrophils, eosinophils, and basophils.\n\n1.  **Analysis of the Measured Profile**:\n    - **High Expression**: The cell exhibits high abundance of EPX ($1.80$), PRG2/MBP ($2.10$), CCR$3$ ($1.60$), IL-5R$\\alpha$ ($1.70$), and Siglec-$8$ ($1.50$). These values are significantly greater than the median of $1$. The expression of CRTH2 ($0.90$) is close to the median.\n    - **Low Expression**: The cell shows very low abundance of MPO ($0.05$), ELANE ($0.08$), and PR3 ($0.06$). These are the defining azurophilic granule proteins of neutrophils.\n    - **Low Expression of Other Markers**: The cell also shows low levels of the primary neutrophil receptors CXCR$2$ ($0.20$) and Fc$\\gamma$RIIIB ($0.10$), and the primary basophil receptors Fc$\\varepsilon$RI ($0.10$) and CD123 ($0.30$). The mast cell-associated proteases CPA$3$ and TPSAB$1$ are negligible ($0.02$ and $0.01$, respectively).\n\n2.  **Comparison to Lineage Definitions**:\n    - **Neutrophil**: A neutrophil is characterized by high levels of MPO, ELANE, PR3, CXCR$2$, and Fc$\\gamma$RIIIB. The unknown cell shows extremely low levels of all these markers. Therefore, the cell is not a neutrophil.\n    - **Basophil**: A basophil is characterized by high expression of Fc$\\varepsilon$RI and CD123, and a lack of EPX. The unknown cell has low Fc$\\varepsilon$RI and CD123, and very high EPX. Therefore, the cell is not a basophil.\n    - **Eosinophil**: An eosinophil is defined by high expression of granule proteins EPX and PRG2/MBP, and surface receptors CCR$3$, IL-5R$\\alpha$, Siglec-$8$, and CRTH2. The unknown cell's profile is an exact match for this description, with all canonical eosinophil markers showing high abundance.\n\n3.  **Conclusion**: Based on a systematic comparison of the data with the provided immunological facts, the unknown cell is unequivocally an eosinophil.\n\n### Option-by-Option Analysis\n\nThe task now is to evaluate each provided option to find the one that gives a correct classification based on an immunologically valid and minimally sufficient decision rule.\n\n**A. Classify as eosinophil if eosinophil-restricted granule proteins are dominant and neutrophil azurophilic proteases are suppressed: specifically, if EPX and PRG$2$ both exceed $1.5$, MPO/ELANE/PR$3$ are each less than $0.5$, and the receptor pattern shows high CCR$3$ and IL-$5$R$\\alpha$ with low Fc$\\varepsilon$RI and CXCR$2$.**\n\n- **Classification**: Eosinophil. This is consistent with our derivation.\n- **Immunological Soundness**: The rule is robust and immunologically sound. It correctly identifies eosinophils based on the *presence* of key eosinophil markers (EPX, PRG2, CCR$3$, IL-5R$\\alpha$) and the *absence* of key neutrophil (MPO, ELANE, PR3, CXCR$2$) and basophil (Fc$\\varepsilon$RI) markers. This combined positive and negative selection constitutes a precise and sufficient rule for discriminating among the three lineages.\n- **Consistency with Data**:\n    - `EPX > 1.5`: True ($1.80 > 1.5$).\n    - `PRG2 > 1.5`: True ($2.10 > 1.5$).\n    - `MPO  0.5`, `ELANE  0.5`, `PR3  0.5`: True ($0.05, 0.08, 0.06  0.5$).\n    - `high CCR3` and `IL-5Rα`: True ($1.60$ and $1.70$ are high).\n    - `low FcεRI` and `CXCR2`: True ($0.10$ and $0.20$ are low).\n- **Verdict**: The rule is immunologically valid, its conditions are met by the data, and it produces the correct classification. **Correct**.\n\n**B. Classify as basophil if type $2$ chemotaxis markers are present even without IgE receptor dominance: specifically, if CCR$3$ and CRTH$2$ are each at least $0.8$ and CD$123$ exceeds $0.2$, regardless of EPX, PRG$2$, or Fc$\\varepsilon$RI levels.**\n\n- **Classification**: Basophil. This contradicts our derivation.\n- **Immunological Soundness**: The rule is flawed. Classifying a cell \"regardless of EPX, PRG2, or Fc$\\varepsilon$RI levels\" is immunologically invalid. EPX is a cardinal marker of eosinophils and is absent in basophils. Fc$\\varepsilon$RI is the canonical high-affinity IgE receptor that defines basophils (and mast cells). A rule that ignores such definitive lineage markers is not sound. CCR$3$ and CRTH2 are expressed by both eosinophils and basophils and are thus not sufficient for discrimination on their own.\n- **Consistency with Data**: The conditions `CCR3 >= 0.8` ($1.60$), `CRTH2 >= 0.8` ($0.90$), and `CD123 > 0.2` ($0.30$) are met. However, because the rule is immunologically unsound, it incorrectly classifies an eosinophil as a basophil.\n- **Verdict**: **Incorrect**.\n\n**C. Classify as neutrophil whenever any chemokine receptor is detectable and MPO is not strongly elevated: specifically, if any of CCR$3$, CXCR$2$, or CRTH$2$ exceeds $0.5$ while MPO is below $1.0$.**\n\n- **Classification**: Neutrophil. This contradicts our derivation.\n- **Immunological Soundness**: This rule is illogical. A neutrophil is defined by the *high expression* of MPO and other specific markers, not by a low level of MPO. Furthermore, using the presence of CCR$3$ or CRTH2 (which are not neutrophil markers) as a positive criterion for a neutrophil classification is fundamentally incorrect.\n- **Consistency with Data**: The conditions `any of CCR3, CXCR2, or CRTH2 > 0.5` (True, $1.60 > 0.5$) and `MPO  1.0` (True, $0.05  1.0$) are met. This faulty rule leads to the incorrect classification of the cell as a neutrophil.\n- **Verdict**: **Incorrect**.\n\n**D. Classify as basophil if any mast cell–type protease is detectable: specifically, if either CPA$3$ or tryptase (TPSAB$1$) is nonzero, irrespective of Fc$\\varepsilon$RI or EPX status.**\n\n- **Classification**: Basophil. This contradicts our derivation.\n- **Immunological Soundness**: The rule is flawed on two counts. First, it conflates basophil and mast cell identity; CPA$3$ and tryptase are primary markers for mast cells, not basophils, which are stated to have minimal amounts. Second, it explicitly ignores Fc$\\varepsilon$RI and EPX, which are essential markers for distinguishing basophils from other granulocytes. Such a rule is immunologically invalid.\n- **Consistency with Data**: The values for CPA$3$ ($0.02$) and tryptase ($0.01$) are non-zero but are essentially background noise. Applying this flawed rule based on trace amounts of incorrect markers leads to the wrong conclusion.\n- **Verdict**: **Incorrect**.", "answer": "$$\\boxed{A}$$", "id": "2862292"}, {"introduction": "Beyond simple identification, we must understand how innate immune cells make critical decisions, such as a macrophage's choice to engulf a target cell in a process called efferocytosis. This exercise models this decision using the sophisticated framework of Bayesian decision theory. You will learn to integrate multiple cellular cues—opsonin deposition ($O$), phosphatidylserine exposure ($P$), and mitochondrial health ($M$)—to derive an optimal decision rule that minimizes the cost of errors, providing a quantitative lens on this vital homeostatic function [@problem_id:2862362].", "problem": "A tissue-resident macrophage must decide whether to engulf a target cell. The macrophage uses three biophysical cues measurable by flow cytometry: surface deposition of an apoptotic-bridging opsonin (for example, milk fat globule-epidermal growth factor 8 (MFG-E8) or complement component $C1q$) with fluorescence intensity $O$, phosphatidylserine (PS) exposure quantified by annexin V binding with intensity $P$, and mitochondrial membrane potential quantified by Tetramethylrhodamine, ethyl ester (TMRE) with intensity $M$. Core immunological facts: apoptotic cells externalize PS and lose mitochondrial membrane potential, while viable cells retain inner-leaflet PS and high mitochondrial membrane potential; apoptotic cell membranes recruit bridging opsonins that facilitate efferocytosis.\n\nAssume that, conditional on the true state, the measured features $O$, $P$, and $M$ are statistically independent and Gaussian-distributed. The two mutually exclusive and exhaustive target states are apoptotic ($A$) and viable ($V$), with class-conditional distributions\n$$\n(O,P,M)\\mid A \\sim \\mathcal{N}\\!\\left(\\boldsymbol{\\mu}_A,\\ \\boldsymbol{\\Sigma}\\right),\\quad (O,P,M)\\mid V \\sim \\mathcal{N}\\!\\left(\\boldsymbol{\\mu}_V,\\ \\boldsymbol{\\Sigma}\\right),\n$$\nwhere\n$$\n\\boldsymbol{\\mu}_A = (6.0,\\ 8.0,\\ 1.5),\\quad \\boldsymbol{\\mu}_V = (2.5,\\ 2.0,\\ 6.0),\n$$\nand\n$$\n\\boldsymbol{\\Sigma} = \\mathrm{diag}\\left(\\sigma_O^2,\\ \\sigma_P^2,\\ \\sigma_M^2\\right) = \\mathrm{diag}\\left(1.0,\\ 4.0,\\ 2.25\\right).\n$$\nThe prior probabilities of encountering apoptotic and viable targets are $P(A)=\\pi_A=0.25$ and $P(V)=\\pi_V=0.75$. The macrophage’s decision incurs a context-dependent cost: deciding to engulf (label as apoptotic) when the target is viable has cost $C(A\\mid V)=8$, and deciding not to engulf (label as viable) when the target is apoptotic has cost $C(V\\mid A)=2$. Correct decisions have zero cost.\n\nUsing only the fundamental definitions of apoptosis-associated cues described above and the general principles of Bayesian risk minimization applied to the given statistical model, identify the optimal decision logic and a quantitative decision criterion that specifies when to engulf (i.e., decide $A$) versus when to refrain (i.e., decide $V$). Choose the option that correctly captures both the structure (how $O$, $P$, and $M$ are combined) and the numerically correct threshold implied by the stated parameters.\n\nA. Engulf if $\\big(P \\ge 6\\ \\text{and}\\ M \\le 3\\big)$ or $\\big(O \\ge 5\\big)$; otherwise do not engulf.\n\nB. Compute the linear score $S = 3.5\\,O + 1.5\\,P - 2.0\\,M$ and engulf if $S  17.36$; otherwise do not engulf.\n\nC. Compute $S' = O + P + M$ and engulf if $S'  12$; otherwise do not engulf.\n\nD. Under a Gaussian naive Bayes model with equal variances $\\sigma_O^2=\\sigma_P^2=\\sigma_M^2=1$, engulf if $P(A\\mid O,P,M)  0.5$; otherwise do not engulf. The threshold on $P(A\\mid O,P,M)$ need not depend on costs or priors.", "solution": "The problem requires the derivation of an optimal decision rule for a macrophage to engulf a target cell, which can be either apoptotic ($A$) or viable ($V$). The decision is to be based on minimizing the Bayesian risk, given a set of biophysical measurements, their statistical distributions, prior probabilities of cell states, and a cost function for misclassification.\n\n### Step 1: Extract Givens\n- **States**: Target cell is either Apoptotic ($A$) or Viable ($V$).\n- **Features**: A vector of measurements $\\mathbf{x} = (O, P, M)^T$.\n  - $O$: Opsonin deposition intensity.\n  - $P$: Phosphatidylserine exposure intensity.\n  - $M$: Mitochondrial membrane potential intensity.\n- **Class-Conditional Distributions**: The features are conditionally independent and Gaussian.\n  - For an apoptotic cell ($A$): $(O,P,M)\\mid A \\sim \\mathcal{N}\\!\\left(\\boldsymbol{\\mu}_A,\\ \\boldsymbol{\\Sigma}\\right)$.\n  - For a viable cell ($V$): $(O,P,M)\\mid V \\sim \\mathcal{N}\\!\\left(\\boldsymbol{\\mu}_V,\\ \\boldsymbol{\\Sigma}\\right)$.\n- **Parameters**:\n  - Mean vector for state $A$: $\\boldsymbol{\\mu}_A = (6.0,\\ 8.0,\\ 1.5)^T$.\n  - Mean vector for state $V$: $\\boldsymbol{\\mu}_V = (2.5,\\ 2.0,\\ 6.0)^T$.\n  - Covariance matrix (common for both states): $\\boldsymbol{\\Sigma} = \\mathrm{diag}\\left(\\sigma_O^2,\\ \\sigma_P^2,\\ \\sigma_M^2\\right) = \\mathrm{diag}\\left(1.0,\\ 4.0,\\ 2.25\\right)$.\n- **Prior Probabilities**:\n  - $P(A) = \\pi_A = 0.25$.\n  - $P(V) = \\pi_V = 0.75$.\n- **Cost Function**:\n  - $C(A\\mid V) = 8$: Cost of deciding $A$ (engulf) when the state is $V$.\n  - $C(V\\mid A) = 2$: Cost of deciding $V$ (do not engulf) when the state is $A$.\n  - $C(A\\mid A) = 0$ and $C(V\\mid V) = 0$: Cost of correct decisions.\n\n### Step 2: Validate Using Extracted Givens\nThe problem statement is evaluated for validity.\n- **Scientific Grounding**: The biological premises are sound. Apoptotic cells are characterized by increased phosphatidylserine (PS) exposure and opsonin deposition, and decreased mitochondrial membrane potential. This is accurately reflected in the mean vectors: $\\mu_{A,O}  \\mu_{V,O}$, $\\mu_{A,P}  \\mu_{V,P}$, and $\\mu_{A,M}  \\mu_{V,M}$. The use of a Gaussian model is a standard and valid approach in statistical pattern recognition for such biological data.\n- **Well-Posedness**: The problem is well-posed. It asks for the optimal decision rule that minimizes a clearly defined expected cost (Bayesian risk). All necessary components—likelihoods ($p(\\mathbf{x}|C)$), priors ($P(C)$), and a cost matrix—are provided, guaranteeing that a unique decision boundary can be derived.\n- **Objectivity and Consistency**: The problem is stated in objective, mathematical terms. There are no contradictions; for instance, the prior probabilities sum to one ($\\pi_A + \\pi_V = 0.25 + 0.75 = 1.0$).\n\n### Step 3: Verdict and Action\nThe problem statement is internally consistent, scientifically grounded, and mathematically well-posed. It is therefore **valid**. I will proceed with the derivation of the solution.\n\n### Derivation of the Optimal Decision Rule\n\nThe goal is to minimize the expected cost, or Bayesian risk. For a given measurement vector $\\mathbf{x}=(O,P,M)^T$, we must decide between class $A$ (engulf) and class $V$ (do not engulf). The conditional risk of taking an action (e.g., deciding $A$) given the observation $\\mathbf{x}$ is the expected cost with respect to the posterior probabilities of the true states.\n\nThe conditional risk of deciding $A$ is:\n$$R(A \\mid \\mathbf{x}) = C(A \\mid A) P(A \\mid \\mathbf{x}) + C(A \\mid V) P(V \\mid \\mathbf{x}) = (0)P(A \\mid \\mathbf{x}) + (8)P(V \\mid \\mathbf{x}) = 8 P(V \\mid \\mathbf{x})$$\nThe conditional risk of deciding $V$ is:\n$$R(V \\mid \\mathbf{x}) = C(V \\mid A) P(A \\mid \\mathbf{x}) + C(V \\mid V) P(V \\mid \\mathbf{x}) = (2)P(A \\mid \\mathbf{x}) + (0)P(V \\mid \\mathbf{x}) = 2 P(A \\mid \\mathbf{x})$$\n\nThe optimal decision is to choose the action with the minimum conditional risk. We should decide to engulf (i.e., classify as $A$) if $R(A \\mid \\mathbf{x})  R(V \\mid \\mathbf{x})$.\n$$8 P(V \\mid \\mathbf{x})  2 P(A \\mid \\mathbf{x})$$\n$$4 P(V \\mid \\mathbf{x})  P(A \\mid \\mathbf{x})$$\n\nUsing Bayes' theorem, $P(C \\mid \\mathbf{x}) = \\frac{p(\\mathbf{x} \\mid C)P(C)}{p(\\mathbf{x})}$, where $p(\\mathbf{x} \\mid C)$ is the class-conditional probability density function (likelihood) and $P(C)$ is the prior probability.\n$$4 \\frac{p(\\mathbf{x} \\mid V)\\pi_V}{p(\\mathbf{x})}  \\frac{p(\\mathbf{x} \\mid A)\\pi_A}{p(\\mathbf{x})}$$\nThe evidence term $p(\\mathbf{x})$ cancels, leading to the likelihood ratio test:\n$$\\frac{p(\\mathbf{x} \\mid A)}{p(\\mathbf{x} \\mid V)}  \\frac{4 \\pi_V}{\\pi_A}$$\nThe threshold $\\tau$ is:\n$$\\tau = \\frac{4 \\times 0.75}{0.25} = \\frac{3}{0.25} = 12$$\nSo, the decision rule is to engulf if $\\frac{p(\\mathbf{x} \\mid A)}{p(\\mathbf{x} \\mid V)}  12$.\n\nIt is more convenient to work with the log-likelihood ratio:\n$$\\ln\\left(\\frac{p(\\mathbf{x} \\mid A)}{p(\\mathbf{x} \\mid V)}\\right)  \\ln(12)$$\n$$\\ln p(\\mathbf{x} \\mid A) - \\ln p(\\mathbf{x} \\mid V)  \\ln(12)$$\n\nFor a multivariate Gaussian distribution with a common covariance matrix $\\mathbf{\\Sigma}$, the log-pdf is:\n$$\\ln p(\\mathbf{x} \\mid C) = \\text{const} - \\frac{1}{2}(\\mathbf{x}-\\boldsymbol{\\mu}_C)^T \\boldsymbol{\\Sigma}^{-1} (\\mathbf{x}-\\boldsymbol{\\mu}_C)$$\nThe difference in log-likelihoods simplifies to a linear function of $\\mathbf{x}$ (a linear discriminant):\n\\begin{align*} \\ln p(\\mathbf{x} \\mid A) - \\ln p(\\mathbf{x} \\mid V) = -\\frac{1}{2}(\\mathbf{x}-\\boldsymbol{\\mu}_A)^T \\boldsymbol{\\Sigma}^{-1} (\\mathbf{x}-\\boldsymbol{\\mu}_A) + \\frac{1}{2}(\\mathbf{x}-\\boldsymbol{\\mu}_V)^T \\boldsymbol{\\Sigma}^{-1} (\\mathbf{x}-\\boldsymbol{\\mu}_V) \\\\ = \\mathbf{x}^T \\boldsymbol{\\Sigma}^{-1}(\\boldsymbol{\\mu}_A - \\boldsymbol{\\mu}_V) - \\frac{1}{2}(\\boldsymbol{\\mu}_A^T \\boldsymbol{\\Sigma}^{-1} \\boldsymbol{\\mu}_A - \\boldsymbol{\\mu}_V^T \\boldsymbol{\\Sigma}^{-1} \\boldsymbol{\\mu}_V)\\end{align*}\nLet us compute the terms.\n$\\boldsymbol{\\mu}_A - \\boldsymbol{\\mu}_V = (6.0-2.5, 8.0-2.0, 1.5-6.0)^T = (3.5, 6.0, -4.5)^T$.\n$\\mathbf{\\Sigma} = \\mathrm{diag}(1.0, 4.0, 2.25)$, so $\\mathbf{\\Sigma}^{-1} = \\mathrm{diag}(1/1.0, 1/4.0, 1/2.25) = \\mathrm{diag}(1.0, 0.25, 4/9)$.\n\nThe linear part of the discriminant is $\\mathbf{x}^T \\boldsymbol{\\Sigma}^{-1}(\\boldsymbol{\\mu}_A - \\boldsymbol{\\mu}_V)$:\n$$(O, P, M) \\begin{pmatrix} 1.0  0  0 \\\\ 0  0.25  0 \\\\ 0  0  4/9 \\end{pmatrix} \\begin{pmatrix} 3.5 \\\\ 6.0 \\\\ -4.5 \\end{pmatrix} = (1.0 \\times 3.5)O + (0.25 \\times 6.0)P + (4/9 \\times -4.5)M$$\n$$= 3.5\\,O + 1.5\\,P - (4/9 \\times 9/2)M = 3.5\\,O + 1.5\\,P - 2.0\\,M$$\nThis linear combination is the score $S$ mentioned in option B.\n\nThe constant part is $-\\frac{1}{2}(\\boldsymbol{\\mu}_A^T \\boldsymbol{\\Sigma}^{-1} \\boldsymbol{\\mu}_A - \\boldsymbol{\\mu}_V^T \\boldsymbol{\\Sigma}^{-1} \\boldsymbol{\\mu}_V)$, which can be simplified as $-\\frac{1}{2}(\\boldsymbol{\\mu}_A+\\boldsymbol{\\mu}_V)^T \\boldsymbol{\\Sigma}^{-1} (\\boldsymbol{\\mu}_A-\\boldsymbol{\\mu}_V)$.\n$\\boldsymbol{\\mu}_A + \\boldsymbol{\\mu}_V = (6.0+2.5, 8.0+2.0, 1.5+6.0)^T = (8.5, 10.0, 7.5)^T$.\nConstant term:\n$$-\\frac{1}{2} (8.5, 10.0, 7.5) \\begin{pmatrix} 1.0  0  0 \\\\ 0  0.25  0 \\\\ 0  0  4/9 \\end{pmatrix} \\begin{pmatrix} 3.5 \\\\ 6.0 \\\\ -4.5 \\end{pmatrix}$$\n$$= -\\frac{1}{2} [(8.5)(1.0)(3.5) + (10.0)(0.25)(6.0) + (7.5)(4/9)(-4.5)]$$\n$$= -\\frac{1}{2} [29.75 + (2.5)(6.0) + (15/2)(4/9)(-9/2)]$$\n$$= -\\frac{1}{2} [29.75 + 15.0 - 15.0] = -\\frac{1}{2}(29.75) = -14.875$$\n\nThe decision rule is:\n$$ (3.5\\,O + 1.5\\,P - 2.0\\,M) - 14.875  \\ln(12) $$\nWe must calculate the threshold value:\n$$ 14.875 + \\ln(12) \\approx 14.875 + 2.4849 = 17.3599 $$\nRounding to two decimal places gives $17.36$.\nSo, the macrophage should engulf if the score $S = 3.5\\,O + 1.5\\,P - 2.0\\,M$ is greater than $17.36$.\n\n### Option-by-Option Analysis\n\n**A. Engulf if $\\big(P \\ge 6\\ \\text{and}\\ M \\le 3\\big)$ or $\\big(O \\ge 5\\big)$; otherwise do not engulf.**\nThis rule defines a decision boundary consisting of planes parallel to the feature space axes. The optimal decision boundary derived from the Gaussian model is a single, tilted hyperplane given by $3.5\\,O + 1.5\\,P - 2.0\\,M = 17.36$. The structure of this rule, a complex logical combination of individual thresholds, is fundamentally different from the linear combination that constitutes the optimal classifier. This rule is a heuristic and is not the optimal Bayesian decision.\n**Verdict: Incorrect.**\n\n**B. Compute the linear score $S = 3.5\\,O + 1.5\\,P - 2.0\\,M$ and engulf if $S  17.36$; otherwise do not engulf.**\nThe derivation above shows that the optimal decision rule is indeed to compute a linear score $S = \\mathbf{x}^T \\boldsymbol{\\Sigma}^{-1}(\\boldsymbol{\\mu}_A - \\boldsymbol{\\mu}_V)$ and compare it to a threshold $k = \\ln(\\frac{4 \\pi_V}{\\pi_A}) + \\frac{1}{2}(\\boldsymbol{\\mu}_A+\\boldsymbol{\\mu}_V)^T \\boldsymbol{\\Sigma}^{-1} (\\boldsymbol{\\mu}_A-\\boldsymbol{\\mu}_V)$.\nOur calculation yielded the score $S = 3.5\\,O + 1.5\\,P - 2.0\\,M$ and the threshold $k \\approx 17.36$. This option matches the derived optimal rule in both its structure (linear combination) and its numerical values (coefficients and threshold).\n**Verdict: Correct.**\n\n**C. Compute $S' = O + P + M$ and engulf if $S'  12$; otherwise do not engulf.**\nThis option proposes a linear score, but with coefficients $(1, 1, 1)$. The correct coefficients, derived from the model parameters, are $(3.5, 1.5, -2.0)$. The proposed coefficients incorrectly weigh the contributions of the features, ignoring their different variances and the different separations between class means for each feature. The sign of the coefficient for $M$ is also wrong; a higher $M$ value indicates a viable cell, so its coefficient in a score for apoptosis should be negative, as in our derivation.\n**Verdict: Incorrect.**\n\n**D. Under a Gaussian naive Bayes model with equal variances $\\sigma_O^2=\\sigma_P^2=\\sigma_M^2=1$, engulf if $P(A\\mid O,P,M)  0.5$; otherwise do not engulf. The threshold on $P(A\\mid O,P,M)$ need not depend on costs or priors.**\nThis option is flawed in multiple ways.\n1.  It assumes a different model (\"equal variances...=1\") than the one specified in the problem, where variances are $1.0$, $4.0$, and $2.25$. An analysis based on a false premise cannot be correct.\n2.  It uses a threshold of $0.5$ for the posterior probability $P(A\\mid \\mathbf{x})$. This corresponds to minimizing the probability of error (a $0-1$ loss function), not the specified cost function where $C(A\\mid V)=8$ and $C(V\\mid A)=2$. The correct threshold on the posterior is $P(A \\mid \\mathbf{x})  4 P(V \\mid \\mathbf{x})$, which simplifies to $P(A \\mid \\mathbf{x})  0.8$.\n3.  The statement \"The threshold on $P(A\\mid O,P,M)$ need not depend on costs or priors\" is fundamentally false in the context of Bayesian decision theory. The threshold is explicitly determined by the cost matrix and prior probabilities. Here, the threshold on the likelihood ratio, $\\tau = \\frac{C(A|V)\\pi_V}{C(V|A)\\pi_A}$, directly depends on both costs and priors. Consequently, the threshold on the posterior probability also depends on them.\n**Verdict: Incorrect.**", "answer": "$$\\boxed{B}$$", "id": "2862362"}, {"introduction": "After deciding to attack a pathogen, neutrophils unleash potent antimicrobial mechanisms, chief among them the respiratory burst. This exercise examines the biochemical cascade that produces reactive oxygen species, a process whose importance is dramatically highlighted in the immunodeficiency Chronic Granulomatous Disease (CGD) [@problem_id:2862311]. By reasoning through the interplay between a defective host enzyme, NADPH oxidase, and the metabolic properties of microbes (e.g., their ability to produce or degrade hydrogen peroxide, $H_2O_2$), you will uncover the precise molecular logic that determines susceptibility to infection.", "problem": "A research group investigates the biochemical basis of defective intracellular killing by neutrophils from a patient with an X-linked loss-of-function mutation in CYBB, which encodes the membrane catalytic subunit $gp91^{\\mathrm{phox}}$ of the phagocyte nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (NOX$2$). You compare opsonophagocytic killing of two otherwise matched clinical isolates that differ only in their catalase phenotype: one is catalase-positive and the other is catalase-negative. Assume phagocytosis, phagolysosomal fusion, acidification, granule delivery, and protease content are intact in both patient and control neutrophils.\n\nAs fundamental biochemical background, consider the following well-tested facts, which you may use as starting points: (i) phagocyte NADPH oxidase transfers electrons from NADPH across the phagosomal membrane to molecular oxygen, generating superoxide, schematically $NADPH + O_2 \\rightarrow NADP^{+} + O_2^{-}$; (ii) superoxide dismutates to hydrogen peroxide, either spontaneously or via superoxide dismutase (SOD), $2\\,O_2^{-} + 2\\,H^{+} \\rightarrow H_2O_2 + O_2$; (iii) myeloperoxidase (MPO) in azurophilic granules uses hydrogen peroxide and chloride to form hypochlorous acid, $H_2O_2 + Cl^{-} \\rightarrow HOCl + OH^{-}$; (iv) catalase degrades hydrogen peroxide, $2\\,H_2O_2 \\rightarrow 2\\,H_2O + O_2$; and (v) many catalase-negative microbes leak metabolically generated $H_2O_2$ into the phagosomal lumen, whereas catalase-positive microbes degrade their own $H_2O_2$.\n\nWhich of the following predictions about bacterial killing and its chemical rescue are most consistent with these principles in the context of CYBB deficiency? Select all that apply.\n\nA. In CYBB-deficient neutrophils, killing of catalase-positive bacteria is significantly impaired, whereas catalase-negative bacteria are killed relatively well, because microbial $H_2O_2$ can be harnessed by myeloperoxidase to generate $HOCl$ even when host $O_2^{-}$ generation is absent.\n\nB. In CYBB-deficient neutrophils, both catalase-positive and catalase-negative bacteria are equally spared, because the absence of $O_2^{-}$ eliminates all sources of $H_2O_2$ within the phagosome.\n\nC. In CYBB-deficient neutrophils, adding exogenous catalase to the extracellular medium rescues killing of catalase-positive bacteria by increasing $O_2$ availability for microbial respiration, which in turn feeds myeloperoxidase.\n\nD. In CYBB-deficient neutrophils, providing exogenous $H_2O_2$ restores killing of catalase-negative bacteria, but this rescue is blocked by a myeloperoxidase inhibitor, consistent with a requirement for $H_2O_2$-dependent halogenation chemistry.\n\nE. In wild-type neutrophils, inhibition of myeloperoxidase does not alter killing of catalase-positive bacteria, because direct toxicity of $O_2^{-}$ substitutes fully for $HOCl$.", "solution": "The problem statement is biochemically and immunologically sound, describing the core pathogenic mechanism of Chronic Granulomatous Disease (CGD) resulting from a `CYBB` mutation. All provided biochemical reactions are correct and serve as valid first principles. The assumptions are clear and allow for a focused analysis of the consequences of NADPH oxidase deficiency. The problem is well-posed and valid.\n\nThe central defect in this patient is the loss of function of the phagocyte NADPH oxidase, NOX2, due to a mutation in its catalytic subunit, $gp91^{\\mathrm{phox}}$. The function of this enzyme is to generate superoxide radicals ($O_2^{-}$) as described in fact (i):\n$$NADPH + 2\\,O_2 \\rightarrow NADP^{+} + H^{+} + 2\\,O_2^{-}$$\n(Note: the stoichiometry $1:2$ for $NADPH:O_2$ is more accurate, but the schematic $1:1$ provided is sufficient for logic).\nThis initial step is blocked in the patient's neutrophils.\n\nIn a healthy individual, the superoxide ($O_2^{-}$) produced is rapidly converted to hydrogen peroxide ($H_2O_2$) via dismutation, as per fact (ii):\n$$2\\,O_2^{-} + 2\\,H^{+} \\rightarrow H_2O_2 + O_2$$\nThis host-generated $H_2O_2$ is then used by the enzyme myeloperoxidase (MPO), which is delivered to the phagosome from azurophilic granules, to produce the highly microbicidal hypochlorous acid ($HOCl$), as per fact (iii):\n$$H_2O_2 + Cl^{-} + H^{+} \\rightarrow HOCl + H_2O$$\n(Note: the provided reaction $H_2O_2 + Cl^{-} \\rightarrow HOCl + OH^{-}$ is a simplified representation, but captures the essential transformation).\n\nIn the patient with `CYBB` deficiency, the entire cascade starting from host $O_2^{-}$ production is absent. Therefore, the neutrophil cannot generate its own $H_2O_2$ to fuel the MPO-dependent killing system. The patient's neutrophils must rely on other sources of antimicrobial agents, or sources of $H_2O_2$.\n\nThis leads to the analysis of the two types of bacteria described:\n$1$. **Catalase-positive bacteria:** These organisms produce $H_2O_2$ as a metabolic byproduct but also possess the enzyme catalase, which degrades it, as per fact (iv): $2\\,H_2O_2 \\rightarrow 2\\,H_2O + O_2$. When phagocytosed by a `CYBB`-deficient neutrophil, there is no $H_2O_2$ from the host, and any $H_2O_2$ produced by the bacterium is immediately destroyed by its own catalase. The phagosome is thus devoid of $H_2O_2$, MPO is inactive, and a primary killing mechanism fails.\n$2$. **Catalase-negative bacteria:** These organisms also produce metabolic $H_2O_2$ but lack catalase. As stated in fact (v), they leak this $H_2O_2$ into their surroundings. When phagocytosed by a `CYBB`-deficient neutrophil, the host MPO (which is intact) can utilize this microbe-derived $H_2O_2$ to generate $HOCl$ and kill the bacterium.\n\nWith this framework, we evaluate each option.\n\n**A. In CYBB-deficient neutrophils, killing of catalase-positive bacteria is significantly impaired, whereas catalase-negative bacteria are killed relatively well, because microbial $H_2O_2$ can be harnessed by myeloperoxidase to generate $HOCl$ even when host $O_2^{-}$ generation is absent.**\nThis statement accurately describes the pathognomonic clinical and microbiological feature of Chronic Granulomatous Disease. Killing of catalase-positive organisms (e.g., *Staphylococcus aureus*, *Aspergillus* species) is defective because the phagosome lacks $H_2O_2$. Killing of catalase-negative organisms (e.g., *Streptococcus pyogenes*) is relatively preserved because the microbes themselves supply the $H_2O_2$ needed for the patient's MPO to function. The reasoning provided is precisely correct.\n**Verdict: Correct.**\n\n**B. In CYBB-deficient neutrophils, both catalase-positive and catalase-negative bacteria are equally spared, because the absence of $O_2^{-}$ eliminates all sources of $H_2O_2$ within the phagosome.**\nThis statement is incorrect. It fails to account for the crucial distinction between catalase-positive and catalase-negative bacteria, which is the central point of the problem. The reasoning, \"the absence of $O_2^{-}$ eliminates all sources of $H_2O_2$,\" is factually wrong, as it ignores the source of $H_2O_2$ provided by catalase-negative microbes, as detailed in given fact (v).\n**Verdict: Incorrect.**\n\n**C. In CYBB-deficient neutrophils, adding exogenous catalase to the extracellular medium rescues killing of catalase-positive bacteria by increasing $O_2$ availability for microbial respiration, which in turn feeds myeloperoxidase.**\nThis statement is biochemically nonsensical. The fundamental problem in killing catalase-positive bacteria is the *absence* of the MPO substrate, $H_2O_2$. Catalase is an enzyme that *destroys* $H_2O_2$. Adding more catalase would only exacerbate the problem, not rescue it. Furthermore, the proposed mechanism is flawed: MPO consumes $H_2O_2$, not $O_2$, as its primary substrate for halogenation. While catalase produces $O_2$, this is irrelevant to the MPO reaction in this context.\n**Verdict: Incorrect.**\n\n**D. In CYBB-deficient neutrophils, providing exogenous $H_2O_2$ restores killing of catalase-negative bacteria, but this rescue is blocked by a myeloperoxidase inhibitor, consistent with a requirement for $H_2O_2$-dependent halogenation chemistry.**\nThis option describes a classic chemical rescue and inhibition experiment. For catalase-negative bacteria, killing is \"relatively well\" but may not be as efficient as in wild-type neutrophils. Providing exogenous $H_2O_2$ would bypass the host's defective NADPH oxidase and directly supply the substrate for the intact MPO system, thus enhancing or \"restoring\" killing to maximal levels. The crucial second part of the statement posits that this rescue effect is abolished by an MPO inhibitor. This is the definitive control experiment to prove that the rescue is indeed mediated by the MPO pathway. The entire logical construct is sound and tests a direct consequence of the given principles. (The same logic applies even more dramatically to catalase-positive bacteria, but the statement as written is biochemically correct).\n**Verdict: Correct.**\n\n**E. In wild-type neutrophils, inhibition of myeloperoxidase does not alter killing of catalase-positive bacteria, because direct toxicity of $O_2^{-}$ substitutes fully for $HOCl$.**\nThis statement is incorrect. It makes a claim about wild-type neutrophils. While MPO-independent killing mechanisms involving reactive oxygen species ($O_2^{-}$, $H_2O_2$) do exist, they are significantly less potent than killing by MPO-generated $HOCl$. Individuals with genetic MPO deficiency exhibit increased susceptibility to certain infections, proving that MPO is not a redundant component. Therefore, inhibiting MPO in a wild-type neutrophil would demonstrably impair killing efficiency; it would not be \"unaltered\". The claim that $O_2^{-}$ toxicity \"fully substitutes\" for $HOCl$ is a factual overstatement and incorrect.\n**Verdict: Incorrect.**", "answer": "$$\\boxed{AD}$$", "id": "2862311"}]}